4//SEC Filing
Ozeroff Christopher David 4
Accession 0001209191-21-066497
CIK 0000907654other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:53 PM ET
Size
8.6 KB
Accession
0001209191-21-066497
Insider Transaction Report
Form 4
Ozeroff Christopher David
EVP & General Counsel
Transactions
- Purchase
Common Stock
2021-11-22$2.26/sh+50,000$113,210→ 50,970 total
Footnotes (1)
- [F1]The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $2.21 to $2.329. Upon request of the SEC staff, ARCA biopharma, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased at each separate price.
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeother
Related Parties
1- filerCIK 0001454996
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:53 PM ET
- Size
- 8.6 KB